Claris Lifesciences Ltd
Claris Lifesciences Limited is engaged in manufacturing of drugs and pharmaceutical products.
- Market Cap ₹ 2,164 Cr.
- Current Price ₹ 397
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -2.14
- Dividend Yield 0.00 %
- ROCE -2.85 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
624.73 | 625.59 | 651.39 | 718.02 | 638.18 | 722.28 | 122.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
439.65 | 450.84 | 462.12 | 486.72 | 503.58 | 659.04 | 161.17 | 10.33 | 25.04 | 12.06 | 1.46 | 0.31 | |
Operating Profit | 185.08 | 174.75 | 189.27 | 231.30 | 134.60 | 63.24 | -39.12 | -10.33 | -25.04 | -12.06 | -1.46 | -0.31 |
OPM % | 29.63% | 27.93% | 29.06% | 32.21% | 21.09% | 8.76% | -32.05% | |||||
14.47 | 15.98 | 15.28 | 11.68 | 78.67 | 104.59 | 24.03 | 21.46 | 36.19 | 7.63 | 0.46 | 0.04 | |
Interest | 52.83 | 46.62 | 55.30 | 64.91 | 52.10 | 31.04 | 3.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 44.46 | 46.38 | 54.34 | 71.79 | 57.96 | 29.58 | 3.56 | 0.14 | 0.10 | 0.00 | 0.00 | 0.00 |
Profit before tax | 102.26 | 97.73 | 94.91 | 106.28 | 103.21 | 107.21 | -22.56 | 10.99 | 11.05 | -4.43 | -1.00 | -0.27 |
Tax % | 12.91% | 19.14% | 26.51% | 29.99% | 21.31% | -29.35% | -10.20% | -5.10% | 15.48% | 59.82% | 401.00% | 0.00% |
89.06 | 79.02 | 69.75 | 74.42 | 81.22 | 138.69 | -20.26 | 11.56 | 9.34 | -7.08 | -5.01 | -0.27 | |
EPS in Rs | 12.38 | 10.93 | 11.66 | 12.73 | 25.42 | -3.71 | 2.12 | 1.71 | -1.30 | -0.92 | -0.05 | |
Dividend Payout % | 11.49% | 16.15% | 18.30% | 17.15% | 70.72% | 0.00% | -53.87% | 94.41% | 116.85% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 95% |
Stock Price CAGR | |
---|---|
10 Years: | 5% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 34.12 | 63.82 | 63.82 | 63.82 | 63.82 | 54.57 | 54.57 | 54.57 | 54.57 | 54.57 | 54.57 | 54.57 |
Reserves | 444.36 | 758.25 | 812.81 | 872.39 | 886.31 | 803.00 | 687.69 | 685.71 | -53.86 | -60.94 | -65.96 | -66.23 |
314.01 | 360.63 | 408.64 | 542.09 | 267.78 | 38.88 | 13.77 | 21.55 | 0.00 | 0.00 | 20.97 | 21.01 | |
364.23 | 337.90 | 284.56 | 326.00 | 515.49 | 372.34 | 246.01 | 176.17 | 23.31 | 28.10 | 0.40 | 0.43 | |
Total Liabilities | 1,156.72 | 1,520.60 | 1,569.83 | 1,804.30 | 1,733.40 | 1,268.79 | 1,002.04 | 938.00 | 24.02 | 21.73 | 9.98 | 9.78 |
489.76 | 528.65 | 661.54 | 804.74 | 505.13 | 38.33 | 33.50 | 51.78 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 123.23 | 185.71 | 41.91 | 174.27 | 173.29 | 1.77 | 6.06 | 2.40 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 17.06 | 17.06 | 17.06 | 16.66 | 627.43 | 350.88 | 222.94 | 230.30 | 0.00 | 0.00 | 0.00 | 0.00 |
526.67 | 789.18 | 849.32 | 808.63 | 427.55 | 877.81 | 739.54 | 653.52 | 24.02 | 21.73 | 9.98 | 9.78 | |
Total Assets | 1,156.72 | 1,520.60 | 1,569.83 | 1,804.30 | 1,733.40 | 1,268.79 | 1,002.04 | 938.00 | 24.02 | 21.73 | 9.98 | 9.78 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
187.37 | 110.24 | 62.32 | 247.75 | 121.96 | 48.58 | -557.42 | -42.14 | -2.03 | -0.14 | 6.17 | -0.11 | |
-103.74 | -143.99 | -204.04 | -340.98 | 217.22 | 233.97 | 610.45 | 28.02 | -6.93 | 0.35 | 0.41 | 0.05 | |
-56.76 | 280.86 | -24.07 | 51.12 | -342.78 | -329.78 | -28.93 | -8.91 | -13.14 | 0.00 | -6.67 | -0.01 | |
Net Cash Flow | 26.87 | 247.11 | -165.79 | -42.11 | -3.60 | -47.23 | 24.10 | -23.03 | -22.10 | 0.21 | -0.09 | -0.06 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 141.02 | 147.81 | 136.64 | 126.04 | 88.53 | 76.74 | 233.95 | |||||
Inventory Days | 204.86 | 215.40 | 219.01 | 259.85 | 58.89 | 0.00 | 0.00 | |||||
Days Payable | 186.82 | 193.14 | 105.22 | 151.80 | 154.80 | |||||||
Cash Conversion Cycle | 159.05 | 170.08 | 250.44 | 234.09 | -7.38 | 76.74 | 233.95 | |||||
Working Capital Days | 99.77 | 124.20 | 161.15 | 127.50 | -118.56 | 231.24 | 1,243.69 | |||||
ROCE % | 20.95% | 14.66% | 12.22% | 12.42% | 10.02% | 10.89% | 2.49% | 1.45% | 2.41% | -62.31% | -2.85% |
Documents
Announcements
-
Exit Letter Of Offer
20 Mar 2018 - Exit Letter of Offer to the remaining public shareholders ('Residual Public Shareholders') of Claris Lifesciences Limited ('Company') for the acquisition of 22,88,697 (Twenty Two Lakh …
-
Announcement under Regulation 30 (LODR)-Updates
12 Mar 2018 - Delisting Announcement with respect to voluntary delisting of the equity shares of Claris Lifesciences Limited (the 'Company') from BSE Limited in accordance with the provisions …
-
Announcement under Regulation 30 (LODR)-Updates
12 Mar 2018 - Exit Offer Public Announcement to the remaining public shareholders ('Residual Public Shareholders') of Claris Lifesciences Limited (the 'Company') made by Athanas Enterprise Private Limited ('AEPL' …
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 7 Mar 2018
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 28 Feb 2018